Literature DB >> 1139320

Neurochemical and morphological changes during the development of cobalt-induced epilepsy in the rat.

P C Emson, M H Joseph.   

Abstract

Following the implantation of cobalt-gelatine pellets into the frontal cortex, epileptiform spikes in both primary and secondary foci developed and reached a peak between 7-12 days post implantation. Histological examination showed a necrotic lesion with terminal and fibre degeneration in brain areas connected with the frontal cortex. Golgi staining at 60 days showed a loss of pyramidal cells in the primary focal area. In the lesion and primary focal areas GABA, glutamate and aspartate were significantly reduced between 5--10 days post implantation. No changes in glutamine and glycine were found in either the lesion or pulmonary focus. No changes in amino acid content were found in the secondary focus or in glass implanted controls at any time. In cobalt-treated rats there were significant reductions in the transmitter related enzymes, glutamate decarboxylase, acetylcholinesterase, choline acetyltransferase and aromatic amino acid decarboxylase in the lesion area and primary and secondary foci at 4--8 days post implantation. Levels of these enzymes had recovered to normal by 24 days. Lactate dehydrogenase was reduced only in the lesion area. Beta-Galactosidase was reduced in the lesion area at 4 days but subsequent rose rapidly paralleling increasing gliosis around the lesion. It is concluded that cobalt-induced epilepsy is associated with relatively selective loss of neuronal tissue and provides a useful model for further investigation relevant to clinical epilepsy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1139320     DOI: 10.1016/0006-8993(75)90288-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

Review 1.  Glutamate, GABA, and CNS disease: a review.

Authors:  J E Walker
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

2.  GABA metabolism in the substantia nigra, cortex, and hippocampus during status epilepticus.

Authors:  C G Wasterlain; C F Baxter; R A Baldwin
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

3.  Pyridoxal phosphate-unrelated inhibition of hippocampal glutamic acid decarboxylase by convulsant pyridoxal sulphate.

Authors:  M Ebadi; A Earle; S Wilt
Journal:  Neurochem Res       Date:  1985-03       Impact factor: 3.996

4.  Effect of repeated convulsive seizures on brain GABA levels.

Authors:  L Ciesielski; S Simler; P Mandel
Journal:  Neurochem Res       Date:  1981-03       Impact factor: 3.996

5.  Dynamics of the protein content in the neurons of the chronic "mirror" eptileptiform focus.

Authors:  R M Khudoerkov
Journal:  Neurosci Behav Physiol       Date:  1980 Jan-Feb

6.  Cholinergic involvement in cobalt-induced epilepsy in the rat.

Authors:  D B Hoover; C R Craig; B K Colasanti
Journal:  Exp Brain Res       Date:  1977-09-28       Impact factor: 1.972

7.  Regional excitatory and inhibitory amino acid levels in epileptic El mouse brain.

Authors:  M Hiramatsu; R Edamatsu; S Suzuki; M Shimada; A Mori
Journal:  Neurochem Res       Date:  1990-08       Impact factor: 3.996

Review 8.  GABA neurons in seizure disorders: a review of immunocytochemical studies.

Authors:  C R Houser
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

9.  The selective inhibition of hippocampal glutamic acid decarboxylase in zinc-induced epileptic seizures.

Authors:  M Itoh; M Ebadi
Journal:  Neurochem Res       Date:  1982-10       Impact factor: 3.996

10.  An analysis of the epileptogenic potency of CO2+- its ability to induce acute convulsive activity in the isolated frog spinal cord.

Authors:  B Buchert-Rau; U Sonnhof
Journal:  Pflugers Arch       Date:  1982-07       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.